Tag Archives: cyclic peptide synthesis

cyclic peptide synthesis advances in diagnosis

Considering that intrinsic resistance was also observed in BCRP/ABCG2 adverse cancer cells, the cyclic peptide synthesis mediated drug efflux may not be the only mechanism contributing to insensitivity of wtEGFR expressing cancer cells to gefitinib, and other mechanisms await to … Continue reading

Posted in Antibody | Tagged , | Leave a comment